Furthermore, these studies imply that targeted loss of PLIN2 in one or more extra-hepatic tissues such as muscle, adipose, or brain may have therapeutic potential in the treatment of obesity associated weight gain and insulin resistance. This evidence concerns the gene PLIN2 and obesity due to melanocortin 4 receptor deficiency.